 |
|
|
|||||
Pankaj Pandey suggests that while Q4 earnings were subdued, FY26 looks promising, particularly for the commodity sector. Cement and steel are highlighted as potential outperformers due to expected earnings improvements and price increases. He also notes the positive impact of declining crude oil prices on OMCs and other user industries, emphasizing the structural benefits for India.
Category:
News and Media
Nifty has surged 10% from its April low, reaching 24,461, prompting experts to advise caution on lumpsum investments due to expected volatility. SIPs remain the preferred route for long-term investors, while staggered allocations via STPs are suggested for those with funds. Auto, international, and tech sector funds have shown double-digit gains since April, driven by strong earnings and global tailwinds.
Category:
News and Media
Glenmark Pharma's innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting heavily pre-treated RRMM patients. The tri-specific antibody showed high response rates and a favorable safety profile in early trials. Complete results will be presented at ASCO 2025. The stock rose 2.2% on Monday, with analysts maintaining a 'Buy' rating.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||